Is ISPH a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

22 people get ISPH articles and Market Currents by email alert.

Get email alerts on ISPH »

HEADLINES:

Merger Arbitrage Mondays: May 23, 2011
Asif Suria • Mon, May 23, 2011 • 2 Comments
17 Stocks Under $5 Being Chased by Big Money Managers
Kapitall • Thu, Apr 28, 2011
Merger Arbitrage Mondays: April 11, 2011
Asif Suria • Tue, Apr 12, 2011 • 2 Comments
Cramer's Mad Money - 6 Earnings and IPOs to Watch for the Coming Week (4/8/11)
SA Editor Miriam Metzinger • Sun, Apr 10, 2011 • 2 Comments
Fred Hassan Isn't the Only Serial Seller in the Pharma Industry
Pharmalot • Thu, Apr 7, 2011 • 1 Comment
The Incredible Shrinking Eye Care Sector
Stephen Simpson • Tue, Apr 5, 2011 • 6 Comments
Short Ideas: 20 Small Cap Stocks With Rising Receivables
Kapitall • Fri, Feb 4, 2011 • 8 Comments
Top 16 Most Underestimated Small Cap Stocks
Kapitall • Mon, Jan 31, 2011
India Allows Use of Generic Versions of Abbott AIDS Drug: Biotech's Latest Tribulations
The Burrill Report • Sun, Jan 9, 2011
Inspire Pharmaceuticals: Looking for Inspiration Following Denufosol Failure
EP Vantage • Thu, Jan 6, 2011
Inspire's Eye Drug Hits Japan
Zacks Investment Research • Tue, Dec 14, 2010 • 1 Comment
Inspire Pharmaceuticals CEO Discusses Q3 2010 Results - Earnings Call Transcript
Thu, Nov 4, 2010
Friday's Top Volume Gainers With Bullish Options Sentiment
Kapitall • Mon, Oct 25, 2010
Today's Strong Volume Gainers With Bullish Options Sentiment
Kapitall • Tue, Oct 19, 2010
Cramer's Mad Money - A Big Kahuna Earnings Week (10/15/10)
SA Editor Miriam Metzinger • Mon, Oct 18, 2010 • 3 Comments
Preparing for Inspire Pharmaceutical's 2011 Phase 3 Catalyst
Tony Pelz • Thu, Sep 2, 2010
Inspire Pharmaceuticals, Inc. Q2 2010 Earnings Call Transcript
Thu, Aug 5, 2010
Inspire Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript
Mon, May 3, 2010
Steven Cohen's SAC Capital Raises Inspire Pharmaceuticals Stake
Market Folly • Tue, Apr 27, 2010
Biotech's Latest Failed Trials, Missed Targets
The Burrill Report • Mon, Jan 25, 2010

To learn more about Seeking Alpha Pro, click here.

Inspire Pharmaceuticals: Looking for Inspiration Following Denufosol Failure
EP Vantage • Thu, Jan 6, 2011
Inspire's Eye Drug Hits Japan
Zacks Investment Research • Tue, Dec 14, 2010 • 1 Comment

Merger Arbitrage Mondays: May 23, 2011
Asif Suria • Mon, May 23, 2011 • 2 Comments
17 Stocks Under $5 Being Chased by Big Money Managers
Kapitall • Thu, Apr 28, 2011
Merger Arbitrage Mondays: April 11, 2011
Asif Suria • Tue, Apr 12, 2011 • 2 Comments
Cramer's Mad Money - 6 Earnings and IPOs to Watch for the Coming Week (4/8/11)
SA Editor Miriam Metzinger • Sun, Apr 10, 2011 • 2 Comments
Fred Hassan Isn't the Only Serial Seller in the Pharma Industry
Pharmalot • Thu, Apr 7, 2011 • 1 Comment
The Incredible Shrinking Eye Care Sector
Stephen Simpson • Tue, Apr 5, 2011 • 6 Comments
Short Ideas: 20 Small Cap Stocks With Rising Receivables
Kapitall • Fri, Feb 4, 2011 • 8 Comments
Top 16 Most Underestimated Small Cap Stocks
Kapitall • Mon, Jan 31, 2011
India Allows Use of Generic Versions of Abbott AIDS Drug: Biotech's Latest Tribulations
The Burrill Report • Sun, Jan 9, 2011
Friday's Top Volume Gainers With Bullish Options Sentiment
Kapitall • Mon, Oct 25, 2010
Today's Strong Volume Gainers With Bullish Options Sentiment
Kapitall • Tue, Oct 19, 2010
Cramer's Mad Money - A Big Kahuna Earnings Week (10/15/10)
SA Editor Miriam Metzinger • Mon, Oct 18, 2010 • 3 Comments
Preparing for Inspire Pharmaceutical's 2011 Phase 3 Catalyst
Tony Pelz • Thu, Sep 2, 2010
Steven Cohen's SAC Capital Raises Inspire Pharmaceuticals Stake
Market Folly • Tue, Apr 27, 2010
Biotech's Latest Failed Trials, Missed Targets
The Burrill Report • Mon, Jan 25, 2010
The Future of Biotech: Party Like It's 1999
Joseph Krueger • Sun, Jan 17, 2010 • 15 Comments
Biotech Discounts Galore
The Burrill Report • Sun, Aug 9, 2009 • 1 Comment
Inspire Pharma Still Looks Good After Earnings
Zacks Investment Research • Thu, May 14, 2009
20 Stocks Which May Be Threatening Your Portfolio
Value Expectations • Mon, May 4, 2009 • 9 Comments
20 Stocks to Avoid from Russell 2000
Value Expectations • Mon, May 4, 2009 • 3 Comments

Inspire Pharmaceuticals CEO Discusses Q3 2010 Results - Earnings Call Transcript
Thu, Nov 4, 2010
Inspire Pharmaceuticals, Inc. Q2 2010 Earnings Call Transcript
Thu, Aug 5, 2010
Inspire Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript
Mon, May 3, 2010
Inspire Pharmaceuticals, Inc. Q2 2009 Earnings Call Transcript
Fri, Jul 31, 2009
Inspire Pharmaceuticals, Inc. Q1 2009 Earnings Call Transcript
Fri, May 8, 2009
Inspire Pharmaceuticals, Inc. F4Q and Full Year 2008 Earnings Call Transcript
Tue, Mar 3, 2009
Inspire Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
Fri, Oct 31, 2008
Inspire Pharmaceuticals, Q2 2008 Earnings Call Transcript
Mon, Aug 11, 2008
Inspire Pharmaceuticals Q4 2007 Earnings Call Transcript
Wed, Feb 27, 2008

Biotech Report: Amarin soars on triglyceride-drug hopes

at MarketWatch.com (Apr 18, 2011)
Cramer's Most Important Lesson In Speculating

at CNBC.com (Apr 8, 2011)
Stocks Close Mixed Despite M&A Boost

at CNBC.com (Apr 5, 2011)
Stocks Fall Ahead of Close as Techs Slip

at CNBC.com (Apr 5, 2011)
Biotech Stocks: Inspire, Questcor lead drug stocks north

at MarketWatch.com (Apr 5, 2011)
Biotech Stocks: Inspire, AVEO take lead in drug-stocks trading

at MarketWatch.com (Feb 17, 2011)
Movers & Shakers: Monday’s biggest gaining and declining stocks

at MarketWatch.com (Jan 3, 2011)
Biotech Stocks: Drug indexes gain as Inspire tanks on study

at MarketWatch.com (Jan 3, 2011)
Cramer Games a Potential Takeover Candidate

at CNBC.com (Oct 15, 2010)
Vital Signs: New drugs for cystic fibrosis bring hope

at MarketWatch.com (Jul 26, 2010)

ISPH vs. ETF Alternatives

Company Description

Currently, there's no company description for ISPH.

Sector: Healthcare

Industry: Drug Manufacturers - Other

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Tuesday, April 5, 2011, 9:37 AM Merck (MRK -0.4%) says it will acquire Inspire Pharmaceuticals (ISPH), a developer of ophthalmic products, in an all-cash deal for $5/share, or ~$430M. The offer represents a 26% premium to yesterday's closing price. Trading in ISPH halted. (PR) Comment!
Monday, January 3, 2011, 8:04 AM Inspire Pharmaceuticals (ISPH) says its second Phase 3 clinical trial with Denufosol for cystic fibrosis didn't achieve statistical significance for its primary efficacy endpoint. The company calls the results 'disappointing and unexpected.' Shares -55.4% to $3.75. (PR) Comment!
Monday, March 15, 2010, 9:00 AM Premarket gainers: ALKS +16%. AMLN +14%. CXG +10%. BPAX +8%. STJ +8%. PVH +6%. CTIC +5%. NVAX +4%. BIXU +4%. BZH +4%.
Losers: BSX -19%. ISPH -15%. FBC -10%. CNX -6%. Comment!
Thursday, January 21, 2010, 9:00 AM Premarket gainers: IMMU +12%. STX +11%. CYTR +9%. EBAY +9%. PLXS +8%. FCS +7%. FITB +6%. FFIV +4%. KEY +4%. SNE +4%.
Losers: ISPH -15%. SVA -8%. GRMN -7%. BCS -4%. RTP -4%. RBS -4%. Comment!
Wednesday, August 5, 2009, 9:00 AM Premarket gainers: INO +42%. RDN +37%. GRMN +20%. PMI +18%. WFMI +16%. USU +14%. BZ +11. TRA +11%. LYG +11%. FWLT +10%. OWW +10%. AIB +8%. RBS +7%. FIG +6%. BCS +5%. CNO +6%. HW +5%. SATC +5%. SAY +4%. ABAT +4%. DVN +4%.
Losers: ACAS -21%. ISPH -9%. PWR -6%. AXL -6%. HCP -5%. BMC -5%. RIG -4%. Comment!
Tuesday, June 17, 2008, 9:56 AM Companies most loved by institutions: IXYS Corp. (IXYS), Progenics Pharmaceuticals (PGNX), Inspire Pharmaceuticals (ISPH), Talbots (TLB), AbitibiBowater (ABH). Comment!

Asif Suria
Merck to acquire Inspire Pharmaceuticals for $430M $MRK $ISPH
4/5/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Kudrna
Big Movers this morning are NSM-RETIRED, NVGN, ISPH, QCOR, DYNT, CBST, FSI, SCEI, ISIL, PRAN, DMND, ASTI
4/5/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

inplayreport.com
ISPH has breakout potential. Tried to sell early today before retracing back up to the high part of the range. Breakout is still above 7.10
4/22/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Drug Recruiter
GILD, NVS, SPPI, IMUC, LIXT, ACTC.OB, CYTX, CVM, DCTH, BOCX, AGEN, ACCP, CUR, CCEL.OB, CRIS, OPXA, CYTK, LGND, ISPH,
9/27/09
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

ISPH Inspire Pharmaceuticals, Inc.

ISPH

Inspire Pharmaceuticals, Inc.